A 70 years old hypeensive patient with stage 5 chronic kidney disease was diagnosed recently with Type 2 diabetes mellitus. He doesn't want to take injectable insulin. Which of the following oral hypoglycemic agents will be preferred in this patient, which won't require any renal dose modification?
Linagliptin
Repaglinide
Vildagliptin
Glimepiride
Answer- A. Linagliptinlinagliptin has the ability to be safely dosed in chronic kidney disease patients. Chronic kidney disease is a major complication in type 2 diabetesLinagliptin .No dose required linagliptin for patients with renal impairment